A multilocus genetic risk score for obesity: Association with BMI and metabolic alterations in a cohort with severe obesity.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
11 Aug 2023
Historique:
medline: 10 11 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Genome wide association studies have identified numerous single nucleotide polymorphisms (SNPs) associated with obesity, yet effect sizes of individual SNPs are small. Therefore, the aim of our study was to investigate whether a genetic risk score (GRS) comprising risk alleles of SNPs identified in the GIANT consortium meta-analyses shows association with body mass index (BMI) and other BMI related metabolic alterations in a cohort with an extreme phenotype. Genotyping of 93 SNPs was performed in 314 obese individuals (mean BMI 40.5 ± 7.8 kg/m², aged 45 ± 12 years), participating in a standardized weight reduction program, and in 74 lean controls (mean BMI 24.6 ± 3.3 kg/m², aged 41.7 ± 13.4 years). Allele numbers of all 93 SNPs were added to a GRS. Anthropometric parameters, parameters of glucose/insulin and lipid metabolism were assessed standardized after a 12 hours fast. GRS was significantly different between controls and obese individuals (unweighted GRS: 86.6 vs 89.0, P = .002; weighted GRS: 84.9 vs 88.3, P = .005). Furthermore, linear regression analysis showed significant associations of GRS with BMI ( P < .0001), weight ( P = .0005), waist circumference ( P = .0039), fat mass ( P < .0001) and epicardial fat thickness ( P = .0032), yet with small effect sizes ( r ² < 0.06). In conclusion, in our study GRS could differentiate between extreme obese and lean individuals, and was associated with BMI and its related traits, yet with small effect sizes.

Identifiants

pubmed: 37565910
doi: 10.1097/MD.0000000000034597
pii: 00005792-202308110-00069
pmc: PMC10419793
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34597

Informations de copyright

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–48.
Berndt SI, Gustafsson S, Mägi R, et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45:501–12.
Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
Yengo L, Sidorenko J, Kemper KE, et al. Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641–9.
Yang J, Bakshi A, Zhu Z, et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nature Genet. 2015;47:1114–20.
Day FR, Loos RJF. Developments in obesity genetics in the era of genome-wide association studies. J Nutrigenet Nutrigenomics. 2011;4:222–38.
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.
Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219–24.
Loos RJF. Recent progress in the genetics of common obesity. Br J Clin Pharmacol. 2009;68:811–29.
Strack C, Baessler A, Wagner F, et al. Mannose-binding lectin in obesity with different degrees of metabolic syndrome abnormalities: association with atherogenic and metabolic traits. J Atheroscler Thromb. 2012;19:539–51.
Fenk S, Fischer M, Strack C, et al. Successful weight reduction improves left ventricular diastolic function and physical performance in severe obesity. Int Heart J. 2015;56:196–202.
Zeller J, Strack C, Fenk S, et al. Relation between obesity, metabolic syndrome, successful long-term weight reduction, and right ventricular function. Int Heart J. 2016;57:441–8.
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–97.
Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30:569–72.
Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol. 2018;6:223–36.
Belsky DW, Moffitt TE, Sugden K, et al. Development and evaluation of a genetic risk score for obesity. Biodemogr Soc Biol. 2013;59:85–100.
Goumidi L, Cottel D, Dallongeville J, et al. Effects of established BMI-associated loci on obesity-related traits in a French representative population sample. BMC Genet. 2014;15:62.
Mägi R, Manning S, Yousseif A, et al. Contribution of 32 GWAS-identified common variants to severe obesity in European adults referred for bariatric surgery. PLoS One. 2013;8:e70735.
Damavandi N, Soleymaniniya A, Bahrami Zadegan S, et al. Development of a genetic risk score for obesity predisposition evaluation. Mol Genet Genom. 2022;297:1495–503.
Gholami F, Rasaei N, Samadi M, et al. The relationship of genetic risk score with cardiometabolic risk factors: a cross-sectional study. BMC Cardiovasc Disord. 2022;22:459.
Zhao X, Xi B, Shen Y, et al. An obesity genetic risk score is associated with metabolic syndrome in Chinese children. Gene. 2014;535:299–302.
Yang S-S, Wang Y, He Y, et al. Genetic scores for BMI related to metabolically unhealthy obesity in an older Chinese population. Clin Endocrinol. 2019;91:759–69.
Song M, Zheng Y, Qi L, et al. Longitudinal analysis of genetic susceptibility and BMI throughout adult life. Diabetes. 2018;67:248–55.
Brandkvist M, Bjørngaard JH, Ødegård RA, et al. Quantifying the impact of genes on body mass index during the obesity epidemic: longitudinal findings from the HUNT Study. BMJ. 2019;366:l4067.

Auteurs

Sabine Julia Maria Sag (SJM)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Stephanie Mueller (S)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Stefan Wallner (S)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.

Christina Strack (C)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Ute Hubauer (U)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Margareta Mohr (M)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Judith Zeller (J)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Thomas Loew (T)

Department of Psychosomatics, University Hospital Regensburg, Regensburg, Germany.

Michael Rehli (M)

Clinic for Internal Medicine 3, University Hospital Regensburg, Regensburg, Germany.

Julia Wimmer (J)

Clinic for Internal Medicine 3, University Hospital Regensburg, Regensburg, Germany.
Deutsches Patent- und Markenamt, München, Germany.

Martina Erika Zimmermann (ME)

Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.

Lars Siegfried Maier (LS)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Marcus Fischer (M)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Andrea Baessler (A)

Clinic for Internal Medicine 2, University Hospital Regensburg, Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH